Dihydrofolate Reductase Inhibitor Antimalarial [EPC]

764 reported adverse events

Drugs of this class: PYRIMETHAMINE

These side effects are most commonly reported by patients taking drugs of the Dihydrofolate Reductase Inhibitor Antimalarial [EPC] class:

# Side effect Count
0 VOMITING 80
1 NAUSEA 76
2 HEADACHE 52
3 PANCYTOPENIA 50
4 PYREXIA 50
5 OFF LABEL USE 49
6 NEUTROPENIA 41
7 DIZZINESS 33
8 DEATH 31
9 DRUG INEFFECTIVE 31
See all common reactions for Dihydrofolate Reductase Inhibitor Antimalarial [EPC]

Drugs of the Dihydrofolate Reductase Inhibitor Antimalarial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL MALARIA 3 0.6000
1 JOINT VIBRATION 2 0.1429
2 CONGENITAL TOXOPLASMOSIS 5 0.1111
3 INFECTION PROTOZOAL 2 0.0800
4 DISSEMINATED TOXOPLASMOSIS 2 0.0714
5 LABYRINTHINE FISTULA 1 0.0667
6 BALAMUTHIA INFECTION 1 0.0556
7 PERITUMOURAL OEDEMA 1 0.0500
8 SPLEEN SCAN ABNORMAL 1 0.0455
9 CEREBRAL TOXOPLASMOSIS 23 0.0444
See all enriched reactions for Dihydrofolate Reductase Inhibitor Antimalarial [EPC]